Yuesheng Qu in Carrollton, Georgia

Medical School: Georgetown University School Of Medicine
Graduation Year: 2012
The Primary Medical Specialty for Yuesheng Qu is listed as: Hematology/oncology
Approximate Years of Experience: 12
PAC (PECOS ID)#: 9638483902
NPI #: 1386900488
NPI Created On: 04/03/2012
NPI Last Updated Listed as: 04/28/2018
Primary Taxonomy Code: 207RH0003X
License Number:
071273
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Ambetter
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Chinese.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Complete blood cell count (red cells, white blood cell, platelets), automated test
3. Hydration infusion into a vein 31 minutes to 1 hour
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
7. Infusion of chemotherapy into a vein up to 1 hour
8. New patient office or other outpatient visit, typically 30 minutes
9. New patient office or other outpatient visit, typically 45 minutes
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient visit, typically 10 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Established patient office or other outpatient, visit typically 40 minutes
15. Initial hospital inpatient care, typically 30 minutes per day
16. Initial hospital inpatient care, typically 50 minutes per day
17. Subsequent hospital inpatient care, typically 15 minutes per day
18. Subsequent hospital inpatient care, typically 25 minutes per day
19. Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic
20. Injection, denosumab, 1 mg